Systemic and renal hemodynamic effects of bupicomide: a new vasodilator.

@article{Chrysant1976SystemicAR,
  title={Systemic and renal hemodynamic effects of bupicomide: a new vasodilator.},
  author={S. Chrysant and P. Adamopoulos and M. Tsuchiya and E. Frohlich},
  journal={American heart journal},
  year={1976},
  volume={92 3},
  pages={
          335-9
        }
}
The systemic and renal hemodyanmic effects of bupicomide were studied in 10 male patients with uncomplicated essential hypertension of moderate severity. Bupicomide significantly reduced systolic, diastolic, and mean arterial pressure and peripheral vascular resistance and this hypotensive effect was associated with a reflexive increase in heart rate, left ventricular ejection rate, and cardiac index; it had no effect upon other reflexive sympathetic adjustments induced by upright tilt and the… Expand
8 Citations
Effects of Amiloride on Arterial Pressure and Renal Function
TLDR
It is concluded that amiloride is an effective antihypertensive and antikaliuretic agents for patients with mild hypertension and normal renal function. Expand
Ticrynafen: a novel uricosuric antihypertensive natriuretic agent.
TLDR
Ticrynafen is a promising therapeutic agent in hypertension, adding a unique uricosuric effect that should improve patient compliance. Expand
Chapter 7: Antihypertensive Agents
Publisher Summary Hypertension results from a repeated sequence of small rises in blood pressure, because of sympathetic hyperactivity, that produce changes in the kidney. The roles of cadmium, lead,Expand
Methods for the assessment of the effects of drugs on renal blood flow.
  • R. M. Pearson
  • Chemistry, Medicine
  • British journal of clinical pharmacology
  • 1979
TLDR
In man, total renal blood flow is about 1.2 1/min, some 25% of the cardiac output and therefore of considerable circulatory importance and there has been increasing interest in accurate methods for its measurement. Expand
Pharmacological activities of fusaric acid (5-butylpicolinic acid).
TLDR
Research findings on the various pharmacological activities of fusaric acid (5-butylpicolinic acid), a mycotoxin produced by several Fusarium species which commonly infect cereal grains and other agricultural commodities are summarized. Expand
Compounds with Potential Activity against Mycobacterium tuberculosis
TLDR
A high-throughput screening of compounds against thiol-deficient Mycobacterium smegmatis strains revealed that some of these compounds were able to modulate the levels of thiols and oxidative stress in M. tuberculosis. Expand
Synthesis, structures, and investigation of noncovalent interactions of 1,3-dimethyl-5-(4ʹ/3ʹ-pyridylazo)-6-aminouracil and their Ni(II) complexes
Abstract In this research paper we report synthesis of two planar ligands, namely 1,3-dimethyl-5-(4ʹ/3ʹ-pyridylazo)-6-aminouracil: HL1 (1) for 4ʹ-pyridyazo- and HL2 (2) for 3ʹ-pyridyazo-group and,Expand
Pathophysiological mechanisms in essential hypertension.

References

SHOWING 1-10 OF 18 REFERENCES
Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.
TLDR
A new piperidino-pyrimidine vasodilator when used in the treatment of 11 hypertensive patients, lowered blood pressure from 188/124 to 159/100 over six to seven days, and retention of sodium retention occurred in all patients. Expand
Combined Therapy with Vasodilator Drugs and Beta‐Adrenergic Blockade in Hypertension: A Comparative Study of Minoxidil and Hydralazine
TLDR
The role of vasodilators used in combination with beta-blockers and diuretics is suggested and the greater therapeutic efficacy of minoxidil is indicated. Expand
Cardiovascular and renal adjustments to a hypotensive agent (l'hydrazinophthalazine: Ciba BA-5968: apresoline).
Since the work of Goldblatt, Lynch, Hanzal, and Summerville which related renal ischemia causally to hypertension (1), it has seemed logical to use renal vasodilators in the treatment of theExpand
Direct renal hemodynamic effects of two vasodilators: diazoxide and acetylcholine.
TLDR
It was concluded that the hemodynamic changes, as well as the handling of electrolytes and water by the kidney, were solely due to the vasodilating properties of both compounds. Expand
II. HEMODYNAMIC ASPECTS OF HYPERTENSION: Physiological Comparison of Labile and Essential Hypertension
TLDR
Patients with labile hypertension demonstrated evidence of a hyperkinetic circulation, and labile hypertensive patients as a group had significantly elevated plasma renin activity, and normal plasma volume which may be treated effectively with beta-adrenergic inhibitors. Expand
Dependence of arterial pressure on intravascular volume in treated hypertensive patients.
TLDR
Although adrenergic blocking drugs interfere with cardiovascular adjustments to intravascular volume expansion, reasons for this quantitative relation between pressure and plasma volume did not emerge, this study emphasizes the importance of precise volume control in maintaining blood-pressure reductions during treatment. Expand
Renal Hyperemia Induced in Man by a New Phthalazine Derivative
  • F. Reubi
  • Medicine
  • Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine
  • 1950
TLDR
The data demonstrate that the drug 5968 (Ciba) is a renal vasodilator in man and the influence of the drug upon the kidney is somewhat similar to that of pyrogenic substances. Expand
Plasma Volume Expansion Resulting from Interference with Adrenergic Function in Normal Man
TLDR
The sympathetic nervous system through its control of venous resistance may provide a means whereby the blood volume can be regulated, and changes occurred in the absence of sodium retention. Expand
Blood volume and exchangeable sodium during treatment of hypertension with guanethidine and hydrochlorothiazide.
TLDR
Antipressor treatment with guanethidine for 8 to 14 days and supplementary treatment with hydrochlorothiazide resulted in a normalization of the above-mentioned parameters both during short-term and long-term management. Expand
The Effect of 1‐Hydrazinophthalazine in Hypertension
The compound 1-hydrazinophthalazine appears to be be an antihypertensive drug of only moderate potency. Based on experience with 50 cases of arterial hypertension, it was found most effective inExpand
...
1
2
...